|
Vaccine Detail
rBCG -Stx2B (Escherichia coli ) |
Vaccine Information |
- Vaccine Name: rBCG -Stx2B (Escherichia coli )
- Target Pathogen: Escherichia coli
- Target Disease: Hemorrhagic colitis
- Vaccine Ontology ID: VO_0004657
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- StxB2
gene engineering:
- Type: Recombinant vector construction
- Description: A novel vaccine against Shiga toxin (Stx)-producing Escherichia coli (STEC) infection using a recombinant Mycobacterium bovis BCG (rBCG) system expressing the Stx2 B subunit (Stx2B) (Fujii et al., 2012).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: rBCG expressing the Stx2 B subunit (Stx2B) (Fujii et al., 2012).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccination Protocol: The mice were given Two intraperitoneal vaccinations of rBCG -Stx2B (Fujii et al., 2012).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: The mice were orally challenged with 10^3 CFU of STEC strain B2F1 (O91: H21) (Fujii et al., 2012).
- Efficacy: The immunized mice survived statistically significantly longer than the nonvaccinated mice (Fujii et al., 2012).
|
References |
Fujii et al., 2012: Fujii J, Naito M, Yutsudo T, Matsumoto S, Heatherly DP, Yamada T, Kobayashi H, Yoshida S, Obrig T. Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice. Clinical and vaccine immunology : CVI. 2012; 19(12); 1932-1937. [PubMed: 23035176].
|
|